The firm's overall revenue rose 8 percent, driven by growth in established pharmaceuticals and medical devices.

Pathologists at academic medical centers are using intentional change-management strategies to overcome some intangible barriers digital uptake.

The deal will help CHOP to expand the reach of its diagnostic innovations, allow Labcorp to grow its offerings, and enable the parties to combine resources to accelerate test development.

With the mark, the system, a fully automated blood culture platform meant for diagnosing bloodstream infections, can be sold throughout the EU.

The test, which leverages technology that mimics a dog's ability to sense disease in humans, analyzes cancer-associated volatile organic compounds found in urine samples.

The parties will work on tests in areas including cancer, genetics, immune disorders, and rare diseases and streamline the path from discovery to national availability.

The assay measures three host-immune proteins to indicate the likelihood of bacterial or viral infections, and is validated for use on Beckman Coulter immunoassay analyzers.

Last week, readers were most interested in a story about FDA clearing Waters' HPV Self-Collection Kit and HPV Assay acquired from Becton Dickinson.

The test detects neuroaxonal damage associated with neuroinflammation in adults diagnosed with relapsing remitting multiple sclerosis.

With the deal, Austin, Texas-based Function adds to its clinical lab offerings, allowing its members to schedule at-home or in-office blood draws.

The study aims to collect data on the performance of blood-based and digital biomarkers to assess their ability to diagnose or predict pathologies associated with Alzheimer's.

The company said its BD Onclarity HPV Self-Collection Kit will improve access to testing for human papillomavirus, which is the main cause of cervical cancer.